ACRV — Acrivon Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Acrivon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	99.6	128	127	179	119
Prepaid Expenses
Total Current Assets	100	132	130	182	120
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.79	6.86	7.91	8.03	7.42
Long Term Investments
Other Long Term Assets
Total Assets	107	181	138	197	130
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.91	6.52	13.3	17.2	15.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.88	10.8	17.1	19.8	17.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	98.7	170	121	177	113
Total Liabilities & Shareholders' Equity	107	181	138	197	130
Total Common Shares Outstanding